nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—CYP3A4—Ezetimibe—atherosclerosis	0.0777	0.211	CbGbCtD
Alfuzosin—CYP3A4—Rosuvastatin—atherosclerosis	0.0777	0.211	CbGbCtD
Alfuzosin—CYP3A4—Simvastatin—atherosclerosis	0.0722	0.196	CbGbCtD
Alfuzosin—CYP3A4—Pravastatin—atherosclerosis	0.0707	0.192	CbGbCtD
Alfuzosin—CYP3A4—Lovastatin—atherosclerosis	0.0707	0.192	CbGbCtD
Alfuzosin—Bursitis—Niacin—atherosclerosis	0.00907	0.0185	CcSEcCtD
Alfuzosin—Laryngitis—Niacin—atherosclerosis	0.00608	0.0124	CcSEcCtD
Alfuzosin—Cholestasis—Niacin—atherosclerosis	0.00577	0.0118	CcSEcCtD
Alfuzosin—Hepatocellular injury—Ezetimibe—atherosclerosis	0.00501	0.0102	CcSEcCtD
Alfuzosin—Hepatocellular injury—Simvastatin—atherosclerosis	0.00477	0.00975	CcSEcCtD
Alfuzosin—Injury—Rosuvastatin—atherosclerosis	0.00476	0.00971	CcSEcCtD
Alfuzosin—Hepatocellular injury—Pravastatin—atherosclerosis	0.00432	0.00881	CcSEcCtD
Alfuzosin—Neuropathy—Pravastatin—atherosclerosis	0.00405	0.00827	CcSEcCtD
Alfuzosin—Injury—Lovastatin—atherosclerosis	0.00403	0.00823	CcSEcCtD
Alfuzosin—Breast disorder—Rosuvastatin—atherosclerosis	0.00395	0.00807	CcSEcCtD
Alfuzosin—Arthritis—Lovastatin—atherosclerosis	0.00381	0.00778	CcSEcCtD
Alfuzosin—Arthritis—Ezetimibe—atherosclerosis	0.00374	0.00764	CcSEcCtD
Alfuzosin—Atrial fibrillation—Simvastatin—atherosclerosis	0.00366	0.00747	CcSEcCtD
Alfuzosin—Bronchitis—Rosuvastatin—atherosclerosis	0.00363	0.00742	CcSEcCtD
Alfuzosin—Arthritis—Simvastatin—atherosclerosis	0.00356	0.00728	CcSEcCtD
Alfuzosin—Injury—Pravastatin—atherosclerosis	0.00341	0.00696	CcSEcCtD
Alfuzosin—Atrial fibrillation—Niacin—atherosclerosis	0.00336	0.00686	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Lovastatin—atherosclerosis	0.00334	0.00681	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.0033	0.00674	CcSEcCtD
Alfuzosin—Jaundice—Rosuvastatin—atherosclerosis	0.00328	0.00671	CcSEcCtD
Alfuzosin—Breast disorder—Ezetimibe—atherosclerosis	0.00328	0.00671	CcSEcCtD
Alfuzosin—Arthritis—Niacin—atherosclerosis	0.00327	0.00669	CcSEcCtD
Alfuzosin—Arthritis—Pravastatin—atherosclerosis	0.00322	0.00658	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.00319	0.00651	CcSEcCtD
Alfuzosin—Sinusitis—Rosuvastatin—atherosclerosis	0.00316	0.00645	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.00312	0.00637	CcSEcCtD
Alfuzosin—Rhinitis—Rosuvastatin—atherosclerosis	0.00303	0.00619	CcSEcCtD
Alfuzosin—Pharyngitis—Rosuvastatin—atherosclerosis	0.003	0.00613	CcSEcCtD
Alfuzosin—Erectile dysfunction—Lovastatin—atherosclerosis	0.00295	0.00602	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.00292	0.00596	CcSEcCtD
Alfuzosin—Orthostatic hypotension—Niacin—atherosclerosis	0.00291	0.00593	CcSEcCtD
Alfuzosin—Erectile dysfunction—Ezetimibe—atherosclerosis	0.00289	0.00591	CcSEcCtD
Alfuzosin—Bronchitis—Simvastatin—atherosclerosis	0.00288	0.00588	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.00282	0.00576	CcSEcCtD
Alfuzosin—Infestation NOS—Ezetimibe—atherosclerosis	0.0028	0.00572	CcSEcCtD
Alfuzosin—Infestation—Ezetimibe—atherosclerosis	0.0028	0.00572	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Lovastatin—atherosclerosis	0.0028	0.00571	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.00278	0.00568	CcSEcCtD
Alfuzosin—Erectile dysfunction—Simvastatin—atherosclerosis	0.00276	0.00563	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.00274	0.00561	CcSEcCtD
Alfuzosin—Jaundice—Ezetimibe—atherosclerosis	0.00273	0.00557	CcSEcCtD
Alfuzosin—Angina pectoris—Niacin—atherosclerosis	0.00268	0.00547	CcSEcCtD
Alfuzosin—Sinusitis—Lovastatin—atherosclerosis	0.00268	0.00547	CcSEcCtD
Alfuzosin—Mental disorder—Rosuvastatin—atherosclerosis	0.00265	0.00541	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.00265	0.00541	CcSEcCtD
Alfuzosin—Bronchitis—Niacin—atherosclerosis	0.00264	0.0054	CcSEcCtD
Alfuzosin—Angina pectoris—Pravastatin—atherosclerosis	0.00264	0.00539	CcSEcCtD
Alfuzosin—Sinusitis—Ezetimibe—atherosclerosis	0.00263	0.00536	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Simvastatin—atherosclerosis	0.00262	0.00535	CcSEcCtD
Alfuzosin—Jaundice—Simvastatin—atherosclerosis	0.0026	0.00532	CcSEcCtD
Alfuzosin—Erectile dysfunction—Niacin—atherosclerosis	0.00253	0.00517	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00252	0.00514	CcSEcCtD
Alfuzosin—Sinusitis—Simvastatin—atherosclerosis	0.0025	0.00512	CcSEcCtD
Alfuzosin—Pharyngitis—Ezetimibe—atherosclerosis	0.00249	0.00509	CcSEcCtD
Alfuzosin—Erectile dysfunction—Pravastatin—atherosclerosis	0.00249	0.00509	CcSEcCtD
Alfuzosin—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00247	0.00504	CcSEcCtD
Alfuzosin—Angioedema—Rosuvastatin—atherosclerosis	0.00241	0.00491	CcSEcCtD
Alfuzosin—Jaundice—Niacin—atherosclerosis	0.00239	0.00488	CcSEcCtD
Alfuzosin—Flushing—Lovastatin—atherosclerosis	0.00238	0.00486	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Pravastatin—atherosclerosis	0.00237	0.00483	CcSEcCtD
Alfuzosin—Jaundice—Pravastatin—atherosclerosis	0.00235	0.00481	CcSEcCtD
Alfuzosin—Sweating—Niacin—atherosclerosis	0.00235	0.0048	CcSEcCtD
Alfuzosin—Flushing—Ezetimibe—atherosclerosis	0.00233	0.00476	CcSEcCtD
Alfuzosin—Angiopathy—Ezetimibe—atherosclerosis	0.00228	0.00466	CcSEcCtD
Alfuzosin—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00227	0.00463	CcSEcCtD
Alfuzosin—Sinusitis—Pravastatin—atherosclerosis	0.00226	0.00463	CcSEcCtD
Alfuzosin—Arthralgia—Rosuvastatin—atherosclerosis	0.00224	0.00458	CcSEcCtD
Alfuzosin—Flushing—Simvastatin—atherosclerosis	0.00222	0.00454	CcSEcCtD
Alfuzosin—Rhinitis—Niacin—atherosclerosis	0.00221	0.00451	CcSEcCtD
Alfuzosin—Mental disorder—Ezetimibe—atherosclerosis	0.0022	0.0045	CcSEcCtD
Alfuzosin—Rhinitis—Pravastatin—atherosclerosis	0.00217	0.00444	CcSEcCtD
Alfuzosin—Back pain—Lovastatin—atherosclerosis	0.00216	0.00441	CcSEcCtD
Alfuzosin—Pharyngitis—Pravastatin—atherosclerosis	0.00215	0.00439	CcSEcCtD
Alfuzosin—Infection—Rosuvastatin—atherosclerosis	0.00213	0.00436	CcSEcCtD
Alfuzosin—Back pain—Ezetimibe—atherosclerosis	0.00212	0.00432	CcSEcCtD
Alfuzosin—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00211	0.0043	CcSEcCtD
Alfuzosin—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.0021	0.0043	CcSEcCtD
Alfuzosin—Mental disorder—Simvastatin—atherosclerosis	0.0021	0.00429	CcSEcCtD
Alfuzosin—Ill-defined disorder—Lovastatin—atherosclerosis	0.00207	0.00423	CcSEcCtD
Alfuzosin—Eye disorder—Niacin—atherosclerosis	0.00206	0.0042	CcSEcCtD
Alfuzosin—Flushing—Niacin—atherosclerosis	0.00204	0.00417	CcSEcCtD
Alfuzosin—Angioedema—Lovastatin—atherosclerosis	0.00204	0.00416	CcSEcCtD
Alfuzosin—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00203	0.00415	CcSEcCtD
Alfuzosin—Malaise—Lovastatin—atherosclerosis	0.00201	0.00411	CcSEcCtD
Alfuzosin—Flushing—Pravastatin—atherosclerosis	0.00201	0.00411	CcSEcCtD
Alfuzosin—Cardiac disorder—Pravastatin—atherosclerosis	0.00201	0.00411	CcSEcCtD
Alfuzosin—Vertigo—Lovastatin—atherosclerosis	0.002	0.00409	CcSEcCtD
Alfuzosin—Angioedema—Ezetimibe—atherosclerosis	0.002	0.00408	CcSEcCtD
Alfuzosin—Angiopathy—Niacin—atherosclerosis	0.002	0.00408	CcSEcCtD
Alfuzosin—Malaise—Ezetimibe—atherosclerosis	0.00197	0.00403	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00196	0.004	CcSEcCtD
Alfuzosin—Ill-defined disorder—Simvastatin—atherosclerosis	0.00194	0.00395	CcSEcCtD
Alfuzosin—Palpitations—Ezetimibe—atherosclerosis	0.00193	0.00395	CcSEcCtD
Alfuzosin—Angioedema—Simvastatin—atherosclerosis	0.00191	0.00389	CcSEcCtD
Alfuzosin—Arthralgia—Lovastatin—atherosclerosis	0.0019	0.00388	CcSEcCtD
Alfuzosin—Chest pain—Lovastatin—atherosclerosis	0.0019	0.00388	CcSEcCtD
Alfuzosin—Dyspepsia—Rosuvastatin—atherosclerosis	0.00189	0.00386	CcSEcCtD
Alfuzosin—Malaise—Simvastatin—atherosclerosis	0.00188	0.00384	CcSEcCtD
Alfuzosin—Discomfort—Lovastatin—atherosclerosis	0.00188	0.00383	CcSEcCtD
Alfuzosin—Vertigo—Simvastatin—atherosclerosis	0.00187	0.00383	CcSEcCtD
Alfuzosin—Chest pain—Ezetimibe—atherosclerosis	0.00186	0.0038	CcSEcCtD
Alfuzosin—Arthralgia—Ezetimibe—atherosclerosis	0.00186	0.0038	CcSEcCtD
Alfuzosin—Dry mouth—Lovastatin—atherosclerosis	0.00186	0.00379	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00185	0.00378	CcSEcCtD
Alfuzosin—Discomfort—Ezetimibe—atherosclerosis	0.00184	0.00376	CcSEcCtD
Alfuzosin—Pain—Rosuvastatin—atherosclerosis	0.00184	0.00375	CcSEcCtD
Alfuzosin—Constipation—Rosuvastatin—atherosclerosis	0.00184	0.00375	CcSEcCtD
Alfuzosin—Dry mouth—Ezetimibe—atherosclerosis	0.00182	0.00372	CcSEcCtD
Alfuzosin—Infection—Lovastatin—atherosclerosis	0.00181	0.00369	CcSEcCtD
Alfuzosin—Thrombocytopenia—Lovastatin—atherosclerosis	0.00178	0.00364	CcSEcCtD
Alfuzosin—Chest pain—Simvastatin—atherosclerosis	0.00178	0.00363	CcSEcCtD
Alfuzosin—Arthralgia—Simvastatin—atherosclerosis	0.00178	0.00363	CcSEcCtD
Alfuzosin—Infection—Ezetimibe—atherosclerosis	0.00177	0.00362	CcSEcCtD
Alfuzosin—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00177	0.00362	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00176	0.00359	CcSEcCtD
Alfuzosin—Discomfort—Simvastatin—atherosclerosis	0.00176	0.00358	CcSEcCtD
Alfuzosin—Nervous system disorder—Ezetimibe—atherosclerosis	0.00175	0.00358	CcSEcCtD
Alfuzosin—Angioedema—Niacin—atherosclerosis	0.00175	0.00358	CcSEcCtD
Alfuzosin—Ill-defined disorder—Pravastatin—atherosclerosis	0.00175	0.00357	CcSEcCtD
Alfuzosin—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00175	0.00357	CcSEcCtD
Alfuzosin—Skin disorder—Ezetimibe—atherosclerosis	0.00173	0.00354	CcSEcCtD
Alfuzosin—Angioedema—Pravastatin—atherosclerosis	0.00172	0.00352	CcSEcCtD
Alfuzosin—Vertigo—Niacin—atherosclerosis	0.00172	0.00352	CcSEcCtD
Alfuzosin—Syncope—Niacin—atherosclerosis	0.00172	0.00351	CcSEcCtD
Alfuzosin—Urticaria—Rosuvastatin—atherosclerosis	0.00171	0.00349	CcSEcCtD
Alfuzosin—Oedema—Simvastatin—atherosclerosis	0.0017	0.00348	CcSEcCtD
Alfuzosin—Malaise—Pravastatin—atherosclerosis	0.0017	0.00347	CcSEcCtD
Alfuzosin—Abdominal pain—Rosuvastatin—atherosclerosis	0.0017	0.00347	CcSEcCtD
Alfuzosin—Vertigo—Pravastatin—atherosclerosis	0.00169	0.00346	CcSEcCtD
Alfuzosin—Palpitations—Niacin—atherosclerosis	0.00169	0.00346	CcSEcCtD
Alfuzosin—Infection—Simvastatin—atherosclerosis	0.00169	0.00346	CcSEcCtD
Alfuzosin—Loss of consciousness—Niacin—atherosclerosis	0.00168	0.00344	CcSEcCtD
Alfuzosin—Thrombocytopenia—Simvastatin—atherosclerosis	0.00167	0.00341	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00166	0.00339	CcSEcCtD
Alfuzosin—Arthralgia—Niacin—atherosclerosis	0.00163	0.00333	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00163	0.00332	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00162	0.00331	CcSEcCtD
Alfuzosin—Arthralgia—Pravastatin—atherosclerosis	0.00161	0.00328	CcSEcCtD
Alfuzosin—Chest pain—Pravastatin—atherosclerosis	0.00161	0.00328	CcSEcCtD
Alfuzosin—Dyspepsia—Lovastatin—atherosclerosis	0.0016	0.00327	CcSEcCtD
Alfuzosin—Dry mouth—Niacin—atherosclerosis	0.0016	0.00326	CcSEcCtD
Alfuzosin—Discomfort—Pravastatin—atherosclerosis	0.00159	0.00324	CcSEcCtD
Alfuzosin—Dyspepsia—Ezetimibe—atherosclerosis	0.00157	0.00321	CcSEcCtD
Alfuzosin—Fatigue—Lovastatin—atherosclerosis	0.00157	0.00321	CcSEcCtD
Alfuzosin—Oedema—Niacin—atherosclerosis	0.00156	0.00319	CcSEcCtD
Alfuzosin—Pain—Lovastatin—atherosclerosis	0.00156	0.00318	CcSEcCtD
Alfuzosin—Constipation—Lovastatin—atherosclerosis	0.00156	0.00318	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00155	0.00317	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00154	0.00315	CcSEcCtD
Alfuzosin—Asthenia—Rosuvastatin—atherosclerosis	0.00154	0.00315	CcSEcCtD
Alfuzosin—Oedema—Pravastatin—atherosclerosis	0.00154	0.00314	CcSEcCtD
Alfuzosin—Fatigue—Ezetimibe—atherosclerosis	0.00154	0.00314	CcSEcCtD
Alfuzosin—Shock—Niacin—atherosclerosis	0.00154	0.00314	CcSEcCtD
Alfuzosin—Infection—Pravastatin—atherosclerosis	0.00153	0.00312	CcSEcCtD
Alfuzosin—Constipation—Ezetimibe—atherosclerosis	0.00153	0.00312	CcSEcCtD
Alfuzosin—Pain—Ezetimibe—atherosclerosis	0.00153	0.00312	CcSEcCtD
Alfuzosin—Tachycardia—Niacin—atherosclerosis	0.00153	0.00312	CcSEcCtD
Alfuzosin—Pruritus—Rosuvastatin—atherosclerosis	0.00152	0.0031	CcSEcCtD
Alfuzosin—Skin disorder—Niacin—atherosclerosis	0.00152	0.0031	CcSEcCtD
Alfuzosin—Hyperhidrosis—Niacin—atherosclerosis	0.00151	0.00309	CcSEcCtD
Alfuzosin—Thrombocytopenia—Pravastatin—atherosclerosis	0.00151	0.00308	CcSEcCtD
Alfuzosin—Feeling abnormal—Lovastatin—atherosclerosis	0.0015	0.00306	CcSEcCtD
Alfuzosin—Dyspepsia—Simvastatin—atherosclerosis	0.0015	0.00306	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00149	0.00304	CcSEcCtD
Alfuzosin—Hyperhidrosis—Pravastatin—atherosclerosis	0.00149	0.00304	CcSEcCtD
Alfuzosin—Feeling abnormal—Ezetimibe—atherosclerosis	0.00147	0.00301	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00147	0.003	CcSEcCtD
Alfuzosin—Diarrhoea—Rosuvastatin—atherosclerosis	0.00147	0.003	CcSEcCtD
Alfuzosin—Fatigue—Simvastatin—atherosclerosis	0.00147	0.003	CcSEcCtD
Alfuzosin—Hypotension—Niacin—atherosclerosis	0.00146	0.00298	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00146	0.00298	CcSEcCtD
Alfuzosin—Pain—Simvastatin—atherosclerosis	0.00146	0.00297	CcSEcCtD
Alfuzosin—Constipation—Simvastatin—atherosclerosis	0.00146	0.00297	CcSEcCtD
Alfuzosin—Urticaria—Lovastatin—atherosclerosis	0.00145	0.00295	CcSEcCtD
Alfuzosin—Abdominal pain—Lovastatin—atherosclerosis	0.00144	0.00294	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00142	0.00291	CcSEcCtD
Alfuzosin—Dizziness—Rosuvastatin—atherosclerosis	0.00142	0.0029	CcSEcCtD
Alfuzosin—Urticaria—Ezetimibe—atherosclerosis	0.00142	0.0029	CcSEcCtD
Alfuzosin—Abdominal pain—Ezetimibe—atherosclerosis	0.00141	0.00288	CcSEcCtD
Alfuzosin—Feeling abnormal—Simvastatin—atherosclerosis	0.0014	0.00287	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.0014	0.00286	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00139	0.00284	CcSEcCtD
Alfuzosin—Somnolence—Niacin—atherosclerosis	0.00139	0.00284	CcSEcCtD
Alfuzosin—Dyspepsia—Niacin—atherosclerosis	0.00138	0.00281	CcSEcCtD
Alfuzosin—Dyspepsia—Pravastatin—atherosclerosis	0.00136	0.00277	CcSEcCtD
Alfuzosin—Rash—Rosuvastatin—atherosclerosis	0.00135	0.00277	CcSEcCtD
Alfuzosin—Dermatitis—Rosuvastatin—atherosclerosis	0.00135	0.00276	CcSEcCtD
Alfuzosin—Urticaria—Simvastatin—atherosclerosis	0.00135	0.00276	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Niacin—atherosclerosis	0.00135	0.00276	CcSEcCtD
Alfuzosin—Abdominal pain—Simvastatin—atherosclerosis	0.00135	0.00275	CcSEcCtD
Alfuzosin—Headache—Rosuvastatin—atherosclerosis	0.00135	0.00275	CcSEcCtD
Alfuzosin—Pain—Niacin—atherosclerosis	0.00134	0.00273	CcSEcCtD
Alfuzosin—Fatigue—Pravastatin—atherosclerosis	0.00133	0.00271	CcSEcCtD
Alfuzosin—Constipation—Pravastatin—atherosclerosis	0.00132	0.00269	CcSEcCtD
Alfuzosin—Pain—Pravastatin—atherosclerosis	0.00132	0.00269	CcSEcCtD
Alfuzosin—Asthenia—Lovastatin—atherosclerosis	0.00131	0.00267	CcSEcCtD
Alfuzosin—Pruritus—Lovastatin—atherosclerosis	0.00129	0.00263	CcSEcCtD
Alfuzosin—Asthenia—Ezetimibe—atherosclerosis	0.00128	0.00262	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Niacin—atherosclerosis	0.00128	0.00261	CcSEcCtD
Alfuzosin—Nausea—Rosuvastatin—atherosclerosis	0.00128	0.00261	CcSEcCtD
Alfuzosin—Feeling abnormal—Pravastatin—atherosclerosis	0.00127	0.00259	CcSEcCtD
Alfuzosin—Pruritus—Ezetimibe—atherosclerosis	0.00126	0.00258	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00126	0.00257	CcSEcCtD
Alfuzosin—Diarrhoea—Lovastatin—atherosclerosis	0.00125	0.00254	CcSEcCtD
Alfuzosin—Urticaria—Niacin—atherosclerosis	0.00124	0.00254	CcSEcCtD
Alfuzosin—Abdominal pain—Niacin—atherosclerosis	0.00124	0.00252	CcSEcCtD
Alfuzosin—Urticaria—Pravastatin—atherosclerosis	0.00122	0.0025	CcSEcCtD
Alfuzosin—Asthenia—Simvastatin—atherosclerosis	0.00122	0.0025	CcSEcCtD
Alfuzosin—Diarrhoea—Ezetimibe—atherosclerosis	0.00122	0.0025	CcSEcCtD
Alfuzosin—Abdominal pain—Pravastatin—atherosclerosis	0.00122	0.00249	CcSEcCtD
Alfuzosin—Pruritus—Simvastatin—atherosclerosis	0.0012	0.00246	CcSEcCtD
Alfuzosin—Dizziness—Lovastatin—atherosclerosis	0.0012	0.00246	CcSEcCtD
Alfuzosin—Dizziness—Ezetimibe—atherosclerosis	0.00118	0.00241	CcSEcCtD
Alfuzosin—Diarrhoea—Simvastatin—atherosclerosis	0.00117	0.00238	CcSEcCtD
Alfuzosin—Vomiting—Lovastatin—atherosclerosis	0.00116	0.00236	CcSEcCtD
Alfuzosin—Rash—Lovastatin—atherosclerosis	0.00115	0.00234	CcSEcCtD
Alfuzosin—Dermatitis—Lovastatin—atherosclerosis	0.00115	0.00234	CcSEcCtD
Alfuzosin—Headache—Lovastatin—atherosclerosis	0.00114	0.00233	CcSEcCtD
Alfuzosin—Vomiting—Ezetimibe—atherosclerosis	0.00114	0.00232	CcSEcCtD
Alfuzosin—Dizziness—Simvastatin—atherosclerosis	0.00113	0.0023	CcSEcCtD
Alfuzosin—Rash—Ezetimibe—atherosclerosis	0.00113	0.0023	CcSEcCtD
Alfuzosin—Dermatitis—Ezetimibe—atherosclerosis	0.00112	0.0023	CcSEcCtD
Alfuzosin—Asthenia—Niacin—atherosclerosis	0.00112	0.00229	CcSEcCtD
Alfuzosin—Headache—Ezetimibe—atherosclerosis	0.00112	0.00228	CcSEcCtD
Alfuzosin—Pruritus—Niacin—atherosclerosis	0.00111	0.00226	CcSEcCtD
Alfuzosin—Asthenia—Pravastatin—atherosclerosis	0.0011	0.00226	CcSEcCtD
Alfuzosin—Pruritus—Pravastatin—atherosclerosis	0.00109	0.00222	CcSEcCtD
Alfuzosin—Vomiting—Simvastatin—atherosclerosis	0.00108	0.00221	CcSEcCtD
Alfuzosin—Nausea—Lovastatin—atherosclerosis	0.00108	0.00221	CcSEcCtD
Alfuzosin—Rash—Simvastatin—atherosclerosis	0.00107	0.00219	CcSEcCtD
Alfuzosin—Dermatitis—Simvastatin—atherosclerosis	0.00107	0.00219	CcSEcCtD
Alfuzosin—Diarrhoea—Niacin—atherosclerosis	0.00107	0.00219	CcSEcCtD
Alfuzosin—Headache—Simvastatin—atherosclerosis	0.00107	0.00218	CcSEcCtD
Alfuzosin—Nausea—Ezetimibe—atherosclerosis	0.00106	0.00217	CcSEcCtD
Alfuzosin—Diarrhoea—Pravastatin—atherosclerosis	0.00105	0.00215	CcSEcCtD
Alfuzosin—Dizziness—Niacin—atherosclerosis	0.00103	0.00211	CcSEcCtD
Alfuzosin—Dizziness—Pravastatin—atherosclerosis	0.00102	0.00208	CcSEcCtD
Alfuzosin—Nausea—Simvastatin—atherosclerosis	0.00101	0.00207	CcSEcCtD
Alfuzosin—Vomiting—Niacin—atherosclerosis	0.000994	0.00203	CcSEcCtD
Alfuzosin—Rash—Niacin—atherosclerosis	0.000986	0.00201	CcSEcCtD
Alfuzosin—Dermatitis—Niacin—atherosclerosis	0.000985	0.00201	CcSEcCtD
Alfuzosin—Headache—Niacin—atherosclerosis	0.00098	0.002	CcSEcCtD
Alfuzosin—Vomiting—Pravastatin—atherosclerosis	0.000979	0.002	CcSEcCtD
Alfuzosin—Rash—Pravastatin—atherosclerosis	0.000971	0.00198	CcSEcCtD
Alfuzosin—Dermatitis—Pravastatin—atherosclerosis	0.00097	0.00198	CcSEcCtD
Alfuzosin—Headache—Pravastatin—atherosclerosis	0.000964	0.00197	CcSEcCtD
Alfuzosin—Nausea—Niacin—atherosclerosis	0.000929	0.0019	CcSEcCtD
Alfuzosin—Nausea—Pravastatin—atherosclerosis	0.000914	0.00187	CcSEcCtD
Alfuzosin—ADRA1B—GPCR downstream signaling—EDN1—atherosclerosis	7.65e-05	0.000541	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—APOA2—atherosclerosis	7.64e-05	0.000541	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—CCL5—atherosclerosis	7.59e-05	0.000537	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CCL3—atherosclerosis	7.58e-05	0.000537	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—KNG1—atherosclerosis	7.32e-05	0.000518	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CNR2—atherosclerosis	7.32e-05	0.000518	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—CXCL8—atherosclerosis	7.31e-05	0.000518	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—MMP3—atherosclerosis	7.3e-05	0.000517	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—UTS2—atherosclerosis	7.29e-05	0.000516	CbGpPWpGaD
Alfuzosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	7.29e-05	0.000516	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—AGTR1—atherosclerosis	7.28e-05	0.000515	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NCF1—atherosclerosis	7.26e-05	0.000514	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—PRKCG—atherosclerosis	7.21e-05	0.000511	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	7.07e-05	0.0005	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—F2—atherosclerosis	7.07e-05	0.0005	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CX3CR1—atherosclerosis	6.99e-05	0.000495	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CASR—atherosclerosis	6.99e-05	0.000495	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—AGT—atherosclerosis	6.94e-05	0.000492	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—EDN1—atherosclerosis	6.94e-05	0.000492	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—CCL5—atherosclerosis	6.89e-05	0.000488	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CX3CL1—atherosclerosis	6.86e-05	0.000485	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CCR2—atherosclerosis	6.86e-05	0.000485	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—EDNRA—atherosclerosis	6.86e-05	0.000485	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CYBA—atherosclerosis	6.83e-05	0.000483	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—EDN1—atherosclerosis	6.79e-05	0.000481	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—PIK3CG—atherosclerosis	6.76e-05	0.000479	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—CCL5—atherosclerosis	6.74e-05	0.000477	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PLAT—atherosclerosis	6.68e-05	0.000473	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PARP1—atherosclerosis	6.68e-05	0.000473	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—GHRL—atherosclerosis	6.68e-05	0.000473	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PLTP—atherosclerosis	6.65e-05	0.00047	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—PRKCG—atherosclerosis	6.55e-05	0.000464	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—VWF—atherosclerosis	6.52e-05	0.000462	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CNR2—atherosclerosis	6.5e-05	0.00046	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—CXCL8—atherosclerosis	6.5e-05	0.00046	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—MMP3—atherosclerosis	6.48e-05	0.000459	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—APOC3—atherosclerosis	6.48e-05	0.000459	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	6.47e-05	0.000458	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—LDLR—atherosclerosis	6.44e-05	0.000456	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—F2—atherosclerosis	6.42e-05	0.000454	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—PRKCG—atherosclerosis	6.41e-05	0.000454	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—AGT—atherosclerosis	6.35e-05	0.000449	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CCL3—atherosclerosis	6.29e-05	0.000445	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—EDN1—atherosclerosis	6.17e-05	0.000437	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—PIK3CG—atherosclerosis	6.14e-05	0.000435	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CCL5—atherosclerosis	6.12e-05	0.000433	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NCF1—atherosclerosis	6.03e-05	0.000427	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—F2—atherosclerosis	5.86e-05	0.000415	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—KNG1—atherosclerosis	5.86e-05	0.000415	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—AGTR1—atherosclerosis	5.83e-05	0.000413	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PRKCG—atherosclerosis	5.82e-05	0.000412	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—VWF—atherosclerosis	5.79e-05	0.00041	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—AGT—atherosclerosis	5.76e-05	0.000408	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—LTA4H—atherosclerosis	5.76e-05	0.000408	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ABCG8—atherosclerosis	5.76e-05	0.000408	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—APOC3—atherosclerosis	5.76e-05	0.000408	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—LDLR—atherosclerosis	5.72e-05	0.000405	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—CCL2—atherosclerosis	5.72e-05	0.000405	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—EDNRA—atherosclerosis	5.69e-05	0.000403	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CCR2—atherosclerosis	5.69e-05	0.000403	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PLG—atherosclerosis	5.68e-05	0.000402	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CYBA—atherosclerosis	5.67e-05	0.000401	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—AGT—atherosclerosis	5.64e-05	0.000399	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—PIK3CG—atherosclerosis	5.61e-05	0.000397	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CCL3—atherosclerosis	5.59e-05	0.000396	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PARP1—atherosclerosis	5.55e-05	0.000393	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PLAT—atherosclerosis	5.55e-05	0.000393	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—GHRL—atherosclerosis	5.55e-05	0.000393	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—SOCS3—atherosclerosis	5.38e-05	0.000381	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NCF1—atherosclerosis	5.35e-05	0.000379	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—F2—atherosclerosis	5.33e-05	0.000377	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—F2—atherosclerosis	5.21e-05	0.000369	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MMP3—atherosclerosis	5.2e-05	0.000368	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IGF2—atherosclerosis	5.17e-05	0.000366	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—AGT—atherosclerosis	5.12e-05	0.000362	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—PIK3CG—atherosclerosis	5.1e-05	0.000361	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CCR2—atherosclerosis	5.05e-05	0.000358	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—EDNRA—atherosclerosis	5.05e-05	0.000358	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CYBA—atherosclerosis	5.03e-05	0.000356	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—APOB—atherosclerosis	5.02e-05	0.000356	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—PIK3CG—atherosclerosis	4.99e-05	0.000353	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—CXCL8—atherosclerosis	4.98e-05	0.000352	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—EDN1—atherosclerosis	4.94e-05	0.00035	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PARP1—atherosclerosis	4.93e-05	0.000349	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—GHRL—atherosclerosis	4.93e-05	0.000349	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PLAT—atherosclerosis	4.93e-05	0.000349	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CCL5—atherosclerosis	4.9e-05	0.000347	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—KNG1—atherosclerosis	4.87e-05	0.000345	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—AGTR1—atherosclerosis	4.84e-05	0.000343	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—LPL—atherosclerosis	4.8e-05	0.000339	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—CCL2—atherosclerosis	4.75e-05	0.000336	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—F2—atherosclerosis	4.73e-05	0.000335	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PLG—atherosclerosis	4.72e-05	0.000334	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PRKCG—atherosclerosis	4.66e-05	0.00033	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ABCG1—atherosclerosis	4.56e-05	0.000322	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—SPP1—atherosclerosis	4.54e-05	0.000322	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PIK3CG—atherosclerosis	4.53e-05	0.00032	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—CXCL8—atherosclerosis	4.52e-05	0.00032	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—SOCS3—atherosclerosis	4.47e-05	0.000316	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—KNG1—atherosclerosis	4.32e-05	0.000306	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MMP3—atherosclerosis	4.31e-05	0.000305	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—AGTR1—atherosclerosis	4.3e-05	0.000304	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IGF2—atherosclerosis	4.29e-05	0.000304	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—LCAT—atherosclerosis	4.28e-05	0.000303	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—FABP4—atherosclerosis	4.28e-05	0.000303	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CCL2—atherosclerosis	4.22e-05	0.000298	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APOA4—atherosclerosis	4.2e-05	0.000298	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PDGFB—atherosclerosis	4.2e-05	0.000297	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PLG—atherosclerosis	4.19e-05	0.000296	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—APOB—atherosclerosis	4.17e-05	0.000295	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—CXCL8—atherosclerosis	4.13e-05	0.000293	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CYP7A1—atherosclerosis	4.13e-05	0.000292	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—AGT—atherosclerosis	4.1e-05	0.00029	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—EDN1—atherosclerosis	4.1e-05	0.00029	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CCL5—atherosclerosis	4.07e-05	0.000288	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—LEP—atherosclerosis	4.02e-05	0.000285	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—APOE—atherosclerosis	4.02e-05	0.000285	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CAV1—atherosclerosis	3.98e-05	0.000282	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—LPL—atherosclerosis	3.98e-05	0.000282	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—APOA1—atherosclerosis	3.97e-05	0.000281	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SOCS3—atherosclerosis	3.97e-05	0.000281	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PRKCG—atherosclerosis	3.87e-05	0.000274	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—ESR1—atherosclerosis	3.84e-05	0.000272	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MMP3—atherosclerosis	3.83e-05	0.000271	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CYP27A1—atherosclerosis	3.82e-05	0.00027	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IGF2—atherosclerosis	3.81e-05	0.00027	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—F2—atherosclerosis	3.79e-05	0.000268	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—SPP1—atherosclerosis	3.77e-05	0.000267	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—CXCL8—atherosclerosis	3.75e-05	0.000266	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—APOB—atherosclerosis	3.7e-05	0.000262	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—CXCL8—atherosclerosis	3.67e-05	0.00026	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—EDN1—atherosclerosis	3.64e-05	0.000258	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PIK3CG—atherosclerosis	3.63e-05	0.000257	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	3.62e-05	0.000256	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ALOX15—atherosclerosis	3.62e-05	0.000256	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	3.62e-05	0.000256	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APOA2—atherosclerosis	3.62e-05	0.000256	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CCL5—atherosclerosis	3.62e-05	0.000256	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ABCG5—atherosclerosis	3.57e-05	0.000253	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—LPL—atherosclerosis	3.54e-05	0.00025	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PDGFB—atherosclerosis	3.49e-05	0.000247	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—MAPK3—atherosclerosis	3.47e-05	0.000246	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—LPA—atherosclerosis	3.45e-05	0.000244	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PRKCG—atherosclerosis	3.44e-05	0.000243	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—INS—atherosclerosis	3.43e-05	0.000243	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—AGT—atherosclerosis	3.4e-05	0.000241	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CCL2—atherosclerosis	3.38e-05	0.000239	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SPP1—atherosclerosis	3.35e-05	0.000237	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—BGN—atherosclerosis	3.34e-05	0.000237	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—APOE—atherosclerosis	3.34e-05	0.000236	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—LEP—atherosclerosis	3.34e-05	0.000236	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CXCL8—atherosclerosis	3.33e-05	0.000236	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IGF1—atherosclerosis	3.32e-05	0.000235	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APOA5—atherosclerosis	3.31e-05	0.000234	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CAV1—atherosclerosis	3.31e-05	0.000234	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—APOA1—atherosclerosis	3.3e-05	0.000233	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	3.19e-05	0.000226	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—ESR1—atherosclerosis	3.19e-05	0.000225	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—SERPINE1—atherosclerosis	3.15e-05	0.000223	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—F2—atherosclerosis	3.15e-05	0.000223	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PDGFB—atherosclerosis	3.1e-05	0.000219	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ALOX5—atherosclerosis	3.08e-05	0.000218	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—AGT—atherosclerosis	3.02e-05	0.000214	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NOS3—atherosclerosis	3.01e-05	0.000213	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PIK3CG—atherosclerosis	3.01e-05	0.000213	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—LEP—atherosclerosis	2.96e-05	0.00021	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—APOE—atherosclerosis	2.96e-05	0.00021	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CAV1—atherosclerosis	2.94e-05	0.000208	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—APOA1—atherosclerosis	2.93e-05	0.000207	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—MAPK3—atherosclerosis	2.88e-05	0.000204	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—INS—atherosclerosis	2.85e-05	0.000202	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—ESR1—atherosclerosis	2.83e-05	0.0002	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CCL2—atherosclerosis	2.8e-05	0.000199	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—F2—atherosclerosis	2.79e-05	0.000198	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—NAMPT—atherosclerosis	2.76e-05	0.000195	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IGF1—atherosclerosis	2.76e-05	0.000195	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—LIPC—atherosclerosis	2.74e-05	0.000194	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APOC3—atherosclerosis	2.73e-05	0.000193	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—LDLR—atherosclerosis	2.71e-05	0.000192	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PIK3CG—atherosclerosis	2.67e-05	0.000189	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CXCL8—atherosclerosis	2.67e-05	0.000189	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CETP—atherosclerosis	2.65e-05	0.000187	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—SERPINE1—atherosclerosis	2.62e-05	0.000185	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—AKT1—atherosclerosis	2.58e-05	0.000183	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—MAPK3—atherosclerosis	2.56e-05	0.000181	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—IL6—atherosclerosis	2.54e-05	0.00018	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SCARB1—atherosclerosis	2.53e-05	0.000179	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—INS—atherosclerosis	2.53e-05	0.000179	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NOS3—atherosclerosis	2.5e-05	0.000177	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CCL2—atherosclerosis	2.49e-05	0.000176	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IGF1—atherosclerosis	2.45e-05	0.000173	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MMP9—atherosclerosis	2.42e-05	0.000171	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HMGCR—atherosclerosis	2.39e-05	0.000169	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NFKB1—atherosclerosis	2.39e-05	0.000169	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MAPK8—atherosclerosis	2.35e-05	0.000166	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—AKT1—atherosclerosis	2.34e-05	0.000166	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SERPINE1—atherosclerosis	2.33e-05	0.000165	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NOS3—atherosclerosis	2.22e-05	0.000157	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CXCL8—atherosclerosis	2.22e-05	0.000157	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—VEGFA—atherosclerosis	2.17e-05	0.000154	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—STAT3—atherosclerosis	2.15e-05	0.000152	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—AKT1—atherosclerosis	2.14e-05	0.000152	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ABCA1—atherosclerosis	2.13e-05	0.000151	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—IL6—atherosclerosis	2.11e-05	0.000149	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MAPK3—atherosclerosis	2.05e-05	0.000145	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MMP9—atherosclerosis	2.01e-05	0.000142	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—TGFB1—atherosclerosis	1.99e-05	0.000141	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NFKB1—atherosclerosis	1.98e-05	0.00014	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	1.97e-05	0.000139	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MAPK8—atherosclerosis	1.95e-05	0.000138	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—AKT1—atherosclerosis	1.94e-05	0.000138	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	1.9e-05	0.000135	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	1.87e-05	0.000133	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.83e-05	0.00013	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—VEGFA—atherosclerosis	1.8e-05	0.000127	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—STAT3—atherosclerosis	1.78e-05	0.000126	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	1.78e-05	0.000126	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	1.76e-05	0.000125	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APOB—atherosclerosis	1.75e-05	0.000124	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	1.73e-05	0.000123	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	1.73e-05	0.000122	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.71e-05	0.000121	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MAPK3—atherosclerosis	1.7e-05	0.000121	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—LPL—atherosclerosis	1.67e-05	0.000118	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TGFB1—atherosclerosis	1.65e-05	0.000117	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GPX1—atherosclerosis	1.63e-05	0.000116	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	1.6e-05	0.000113	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CD36—atherosclerosis	1.59e-05	0.000113	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	1.58e-05	0.000112	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	1.51e-05	0.000107	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.51e-05	0.000107	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IL6—atherosclerosis	1.5e-05	0.000106	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PPARA—atherosclerosis	1.48e-05	0.000105	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	1.47e-05	0.000104	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—AGT—atherosclerosis	1.43e-05	0.000101	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APOE—atherosclerosis	1.4e-05	9.93e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CAV1—atherosclerosis	1.39e-05	9.84e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APOA1—atherosclerosis	1.39e-05	9.82e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—AKT1—atherosclerosis	1.38e-05	9.8e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.27e-05	8.96e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IL6—atherosclerosis	1.25e-05	8.82e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PPARG—atherosclerosis	1.22e-05	8.65e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—INS—atherosclerosis	1.2e-05	8.48e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—AKT1—atherosclerosis	1.15e-05	8.13e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IL6—atherosclerosis	1.11e-05	7.83e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ALB—atherosclerosis	1.1e-05	7.78e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—NOS3—atherosclerosis	1.05e-05	7.44e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	1.02e-05	7.22e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PTGS2—atherosclerosis	9.61e-06	6.8e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—AKT1—atherosclerosis	4.83e-06	3.42e-05	CbGpPWpGaD
